Prevalence of malaria and anaemia among HIV infected pregnant women receiving co-trimoxazole prophylaxis in Tanzania: a cross sectional study in Kinondoni Municipality
- PMID: 24761799
- PMCID: PMC4014408
- DOI: 10.1186/2050-6511-15-24
Prevalence of malaria and anaemia among HIV infected pregnant women receiving co-trimoxazole prophylaxis in Tanzania: a cross sectional study in Kinondoni Municipality
Abstract
Background: HIV-infected pregnant women are particularly more susceptible to the deleterious effects of malaria infection particularly anaemia. In order to prevent opportunistic infections and malaria, a policy of daily co-trimoxazole prophylaxis without the standard Suphadoxine-Pyrimethamine intermittent preventive treatment (SP-IPT) was introduced to all HIV infected pregnant women in the year 2011. However, there is limited information about the effectiveness of this policy.
Methods: This was a cross sectional study conducted among HIV-infected pregnant women receiving co-trimoxazole prophylaxis in eight public health facilities in Kinondoni Municipality from February to April 2013. Blood was tested for malaria infection and anaemia (haemoglobin <11 g/dl). Data were collected on the adherence to co-trimoxazole prophylaxis and other risk factors for malaria infection and anaemia. Pearson chi-square test, Fischer's exact test and multivariate logistic regression were used in the statistical analysis.
Results: This study enrolled 420 HIV infected pregnant women. The prevalence of malaria infection was 4.5%, while that of anaemia was 54%. The proportion of subjects with poor adherence to co-trimoxazole was 50.5%. As compared to HIV infected pregnant women with good adherence to co-trimoxazole prophylaxis, the poor adherents were more likely to have a malaria infection (Adjusted Odds Ratio, AOR = 6.81, 95% CI = 1.35-34.43, P = 0.02) or anaemia (AOR = 1.75, 95% CI = 1.03-2.98, P = 0.039). Other risk factors associated with anaemia were advanced WHO clinical stages, current malaria infection and history of episodes of malaria illness during the index pregnancy.
Conclusion: The prevalence of malaria was low; however, a significant proportion of subjects had anaemia. Good adherence to co-trimoxazole prophylaxis was associated with reduction of both malaria infection and anaemia among HIV infected pregnant women.
Similar articles
-
Implementation of co-trimoxazole preventive therapy policy for malaria in HIV-infected pregnant women in the public health facilities in Tanzania.Drug Healthc Patient Saf. 2016 Dec 13;8:91-100. doi: 10.2147/DHPS.S119073. eCollection 2016. Drug Healthc Patient Saf. 2016. PMID: 28008284 Free PMC article.
-
Protective efficacy of prolonged co-trimoxazole prophylaxis in HIV-exposed children up to age 4 years for the prevention of malaria in Uganda: a randomised controlled open-label trial.Lancet Glob Health. 2014 Dec;2(12):e727-36. doi: 10.1016/S2214-109X(14)70329-8. Lancet Glob Health. 2014. PMID: 25433628 Clinical Trial.
-
Cost-effectiveness of malaria preventive treatment for HIV-infected pregnant women in sub-Saharan Africa.Malar J. 2017 Oct 6;16(1):403. doi: 10.1186/s12936-017-2047-x. Malar J. 2017. PMID: 28985732 Free PMC article.
-
The expanding role of co-trimoxazole in developing countries.Lancet Infect Dis. 2015 Mar;15(3):327-39. doi: 10.1016/S1473-3099(14)71011-4. Epub 2015 Jan 21. Lancet Infect Dis. 2015. PMID: 25618179 Review.
-
Scaling-up co-trimoxazole prophylaxis in HIV-exposed and HIV-infected children in high HIV-prevalence countries.Lancet Infect Dis. 2007 Oct;7(10):686-93. doi: 10.1016/S1473-3099(07)70239-6. Lancet Infect Dis. 2007. PMID: 17897611 Review.
Cited by
-
A Public Health Paradox: The Women Most Vulnerable to Malaria Are the Least Protected.PLoS Med. 2016 May 3;13(5):e1002014. doi: 10.1371/journal.pmed.1002014. eCollection 2016 May. PLoS Med. 2016. PMID: 27139032 Free PMC article.
-
Implementation of co-trimoxazole preventive therapy policy for malaria in HIV-infected pregnant women in the public health facilities in Tanzania.Drug Healthc Patient Saf. 2016 Dec 13;8:91-100. doi: 10.2147/DHPS.S119073. eCollection 2016. Drug Healthc Patient Saf. 2016. PMID: 28008284 Free PMC article.
-
Malaria prevalence in HIV-positive children, pregnant women, and adults: a systematic review and meta-analysis.Parasit Vectors. 2022 Sep 14;15(1):324. doi: 10.1186/s13071-022-05432-2. Parasit Vectors. 2022. PMID: 36104731 Free PMC article.
-
The Effect of Malaria and HIV Co-Infection on Anemia: A Meta-Analysis.Medicine (Baltimore). 2016 Apr;95(14):e3205. doi: 10.1097/MD.0000000000003205. Medicine (Baltimore). 2016. PMID: 27057848 Free PMC article.
-
Prevalence of anemia among people living with HIV: A systematic review and meta-analysis.EClinicalMedicine. 2022 Jan 26;44:101283. doi: 10.1016/j.eclinm.2022.101283. eCollection 2022 Feb. EClinicalMedicine. 2022. PMID: 35128369 Free PMC article.
References
-
- Steketee R, Wirima J, Bloland P, Chilima B, Mermin J. Impairment of a pregnant woman’s acquired ability to limit Plasmodium falciparum by infection with Human Immunodeficiency Virus type-1. Am J Trop Med Hyg. 1996;55(1):42–49. - PubMed
-
- Ter Kuile FO, Parise ME, Verhoeff FH, Udhayakumar V, Newman RD, Van Eijk AM, Rogerson SJ, Steketee RW. The burden of co-infection with Human Immunodeficiency Virus type 1 and malaria in pregnant women in Sub-Saharan Africa. Am J Trop Med Hyg. 2004;71(2):41–54. - PubMed
-
- World Health Organization. Guideline on co-trimoxazole prophylaxis for HIV-related infections among children, adolescents and adults in resource-limited settings. Recommendations for a public health approach. Geneva; 2006.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous